Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the “Selectivity Pocket”, Substrate-Binding Site, and NAD+-Binding Site

The NAD+-dependent deacetylase SIRT2 represents an attractive target for drug development. Here, we designed and synthesized drug-like SIRT2-selective inhibitors based on an analysis of the putative binding modes of recently reported SIRT2-selective inhibitors, and evaluated their SIRT2-inhibitory activity. This led us to develop a more drug-like diketopiperazine structure as a “hydrogen bond (H-bond) hunter” to target the substrate-binding site of SIRT2. Thioamide 53, a conjugate of diketopiperazine and 2-anilinobenzamide which is expected to occupy the “selectivity pocket” of SIRT2, exhibited potent SIRT2-selective inhibition. Inhibition of SIRT2 by 53 was mediated by the formation of a 53-ADP-ribose conjugate, suggesting that 53 is a mechanism-based inhibitor targeting the “selectivity pocket”, substrate-binding site, and NAD+-binding site. Furthermore, 53 showed potent antiproliferative activity towards breast cancer cells and promoted neurite outgrowth of Neuro-2a cells. These findings should pave th...